Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

B-Cell Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Lymphocytic Neoplasm
B-Cell Neoplasm

Hematologic Malignancy

B-Cell Neoplasm

CI-CAN-00000470Explore in graph →

HematologicNon-malignant2,097 active trials46 approved drugs301 evidence items

NCIt: C27907

Overview
Statistics
Survival
Genomics29
Variants & evidence301
Drugs45
Trials7500
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (305)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 151–175 of 305 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Clinical and biological significance of RAS mutations in multiple myeloma.
· Leukemia · 2008 · PMID 18528420 · validated civic_curation pubmed
SF3B1 mutations in chronic lymphocytic leukemia.
· Blood · 2013 · PMID 23568491 · validated civic_curation pubmed
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.
· Blood · 2014 · PMID 24740809 · validated civic_curation pubmed
Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
· J Clin Oncol · 2011 · PMID 21747090 · validated civic_curation pubmed
Ibrutinib in previously treated Waldenström's macroglobulinemia.
· N Engl J Med · 2015 · PMID 25853747 · validated civic_curation pubmed
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
· Blood · 2012 · PMID 22077063 · validated civic_curation pubmed
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
· Lancet Oncol · 2015 · PMID 26256760 · validated civic_curation

Showing 151–175 of 305 publications

← Previous
1
…
6
7
8
…
13
Next →

BRAF mutations in hairy-cell leukemia.

· N Engl J Med · 2011 · PMID 21663470 · validated civic_curation pubmed

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.

· Blood · 2008 · PMID 18689542 · validated civic_curation pubmed

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

· Blood · 2013 · PMID 23086750 · validated civic_curation pubmed

Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.

· JAMA Oncol · 2015 · PMID 26182309 · validated civic_curation pubmed

The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.

· Clin Cancer Res · 2006 · PMID 17020971 · validated civic_curation pubmed

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.

· J Clin Oncol · 2017 · PMID 28418267 · validated civic_curation pubmed

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

· Proc Natl Acad Sci U S A · 2010 · PMID 20018760 · validated civic_curation pubmed

Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.

· Ann Hematol · 2017 · PMID 27815723 · validated civic_curation pubmed

Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

· Nat Med · 2015 · PMID 25962120 · validated civic_curation pubmed

Characterization of leukemias with ETV6-ABL1 fusion.

· Haematologica · 2016 · PMID 27229714 · validated civic_curation pubmed

Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.

· Lancet Haematol · 2021 · PMID 33357483 · validated civic_curation pubmed

Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.

· Cancer Sci · 2021 · PMID 34159682 · validated civic_curation pubmed

EZH2 mutations are frequent and represent an early event in follicular lymphoma.

· Blood · 2013 · PMID 24052547 · validated civic_curation pubmed

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.

· Blood · 2019 · PMID 30510083 · validated civic_curation pubmed

The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.

· Blood · 1991 · PMID 1671560 · validated civic_curation pubmed

Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.

· J Clin Oncol · 1994 · PMID 7989935 · validated civic_curation pubmed

Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.

· Leuk Lymphoma · 1999 · PMID 10194126 · validated civic_curation pubmed

Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.

· Blood · 1991 · PMID 1991160 · validated civic_curation pubmed